NCT00622349View on ClinicalTrials.gov

Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

707

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

March 31, 2009

Study Completion Date

December 31, 2009

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

Cisplatin, Ifosfamide, Gemcitabine

Cisplatin 50 mg/m² day 1 Ifosfamide 3g/m² day 1 (+ uromitexan rescue) Gemcitabine 1 g/m² days 1 and 8 Cycles every 3 weeks

DRUG

Ifosfamide, Gemcitabine

Ifosfamide 3g/m² day 1 (+ uromitexan rescue) Gemcitabine 1 g/m² days 1 and 8 Cycles every 3 weeks

DRUG

Cisplatin, docetaxel

Cisplatin 50 mg/m² day 1 Docetaxel 75 mg/m² day 1 Cycles every 3 weeks

Trial Locations (4)

1000

Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet, Brussels

Unknown

Pneumology department of CHU Lille, Lille

Hellenic Cancer Institute - St Savas Oncology Hospital, Athens

Medical Oncology Hospital de Sagunto, Valencia

All Listed Sponsors
lead

European Lung Cancer Working Party

OTHER

NCT00622349 - Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter